Papillary fibroelastoma of the left atrial wall: a case report
© Bicer et al; licensee BioMed Central Ltd. 2009
Received: 15 December 2008
Accepted: 01 July 2009
Published: 01 July 2009
Cardiac papillary fibroelastoma is a rare, benign cardiac tumor. It often arises from valvular endocardium, and non-valvular endocardial location is rare. Although transthoracic echocardiography is usually sufficient for the diagnosis of most cardiac tumors, small tumors such as papillary fibroelastoma may be missed. Transesophageal echocardiography is superior to transthoracic echocardiography in diagnosing these tumors. Despite their benign histology, and independent of their size, they should be resected surgically because of their high potential for embolization.
In this report, we present a case of papillary fibroelastoma located on the left atrial wall, presenting with symptoms of cerebral ischemia. The patient was treated surgically for the prevention of further embolic complications. Pertinent literature is also reviewed for this rare and benign cardiac tumor.
Cardiac papillary fibroelastoma (PFE) is a rare, benign cardiac tumor. Usually, it arises from valvular endocardium. Nonvalvular endocardial location is rare, and may confuse the clinician for the differential diagnosis between organized mobile thrombus, pedinculated myxoma and fibroelastoma [1–3]. Herein, we present a case of PFE presenting with symptoms of cerebral ischemia. The pertinent literature is also reviewed for this rare and benign cardiac tumor.
The incidence of cardiac tumors in autopsy series is estimated at 0.021%, and cardiac PFE constitutes 10% of these . It is the third most frequent primary cardiac tumor, after myxoma and fibroma [1–3], and the most common primary tumor of heart valves. They are often found on aortic and mitral valves, less frequently on tricuspid and pulmonary valves, and rarely along atrial or ventricular walls [5–9].
The histogenesis of PFE is still unclear [3, 6, 8]. There are several hypotheses about the etiology. They have been considered as neoplasms, hamartomas, organized thrombi, and unusual endocardial responses to infection or hemodynamic trauma [3, 8]. Kurup et al. reported that thoracic irradiation and open cardiac surgery might be the potential causes for this pathology . On the other hand, histochemical presence of fibrin, hyaluronic acid, and laminated elastic fibers supports the hypothesis that PFE may be related to organizing thrombi [8, 10]. A recent study proposed that it may be related to a chronic form of viral endocarditis, based on the presence of dendritic cells and cytomegalovirus in some patients .
The location of PFE in the heart is very important because of its potential to embolize. Left-sided tumors may cause stroke, myocardial infarction, mesenteric ischemia, renal infarction and limb ischemia. Depending on their size and mobility, PFE can also give rise to obstruction of left ventricular filling during diastole, resulting in recurrent pulmonary edema. Right-sided cardiac tumors remain predominantly asymptomatic until they become large enough to interfere with intracardiac blood flow, alter hemodynamic function or induce arrhythmias. These features can mimic the clinical picture of tricuspid valve stenosis . Chronic, repeating pulmonary embolization may lead to significant hypoxemia and severe pulmonary hypertension [12, 13]. Other symptoms are dyspnea, chest discomfort, and palpitations.
The diagnosis is usually made by echocardiography. Although TTE is sufficient for the diagnosis of most cardiac tumors, small tumors such as PFE may be missed, as evidenced by the present case. TEE is superior to TTE in diagnosing these tumors [2, 9]. Echocardiographic features of PFE include; 1. Small lesions, typically less than 1 cm in diameter, but may be as large as 3 to 4 cm; 2. Highly mobile mass with a pedicle or stalk attached to the valve or endocardium; and 3. Frond-like appearance . Recently, more cases diagnosed by magnetic resonance imaging and multislice spiral computed tomography have been reported [14, 15].
There is still a debate for surgical treatment of asymptomatic patients. Despite their benign histology, surgical excision is mandated regardless of the size if the patient has recurrent embolic complications. If the patient has cerebral embolisation, the operation should be delayed at least 4 weeks in order to prevent hemorrhagic transformation of the ischemic infarct. Several atrial incisions might be used for surgical exposure. We prefer trans-septal or extended vertical trans-atrial septal (Guiraudon) incisions for complete resection of left atrial tumors with optimal exposure, if the patient does not have dilated left atrium. Differential diagnosis of PFE encompasses other heart tumors, thrombi, vegetations, valvular calcification and Lambl's excrescences. Despite its typical shape, imaging techniques may fail to differentiate PFE from other cardiac tumors, as evidenced in this case. Histological investigation after surgical resection is mandatory to confirm the diagnosis. Cardiac myxoma is a predominant left atrial tumor, and is usually attached to the atrial septum by a stalk. Histologically, myxoma differs from PFE by the presence of polygonal myxoma cells and blood vessels within the papillae. Cardiac fibroma frequently demonstrates calcification and cystic degeneration. Cardiac rhabdomyomae are predominant in infants and children. Metastic tumors of the heart are more frequent than primary tumors . Unlike PFE, malignant tumors commonly involve the pericardium and myocardium, and are usually accompanied by systemic symptoms. However, with both primary and metastatic tumors, the clinical course may be complicated by emboli.
In conclusion, PFE are histologically benign tumors of the heart. They have the potential for peripheral or pulmonary embolisation regardless of their size. Since it is usually small, it cannot be detected reliably by TTE, thus TEE should be considered for a patient with an unexplained neurological ischemic event. Although there is a debate for resection of the asymptomatic PFE, surgical excision is mandated regardless of the size in order to hinder future embolic and hemodynamic complications.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Tazelaar HD, Locke TJ, McGregor CGA: Pathology of surgically excised primary cardiac tumors. Mayo Clin Proc. 1992, 67: 957-65.View ArticlePubMedGoogle Scholar
- Buttany J, Nair V, Ahluwaha MS, El Demellwy D, Siu S, Fiendel C: Papillary fibroelastoma of the interatrial Septum: a case report. J Card Surg. 2004, 19: 349-53. 10.1111/j.0886-0440.2004.4073_11.x.View ArticleGoogle Scholar
- Kurup AN, Tazelaar HD, Edwards WD, Purke AP, Virmani R, Klarich KW, Orszulak TA: Iatrogenic cardiac papillary fibroelastoma: a study of 12 cases (1990 to 2000). Hum Pathol. 2002, 33: 1165-9. 10.1053/hupa.2002.130105.View ArticlePubMedGoogle Scholar
- Reynen K: Frequency of primary tumors of the heart. Am J Cardiol. 1996, 77: 107-10.1016/S0002-9149(97)89149-7.View ArticlePubMedGoogle Scholar
- Eslami-Varzaneh F, Brun EA, Sears-Regan P: An unusual case of multipapillary fibroelastoma: review of literature. Cardiovasc Pathol. 2003, 12: 170-3. 10.1016/S1054-8807(03)00033-4.View ArticlePubMedGoogle Scholar
- Ngaage DL, Mullany CJ, Daly RC, Dearani JA, Edwards WD, Tazelaar HD, McGregor CG, Orszulak TA, Puga FJ, Schaff HV, Sundt TM, Zehr KJ: Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005, 80: 1712-8. 10.1016/j.athoracsur.2005.04.030.View ArticlePubMedGoogle Scholar
- Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB: Papillary fibroelastoma: Echocardiographic carecteristics for diagnosis and pathologic correlation. Am Coll Cardiol. 1997, 30 (3): 784-790. 10.1016/S0735-1097(97)00211-8.View ArticleGoogle Scholar
- Howard RA, Aldea GS, Shapira OM, Kasznica JM, Dawidoff R: Papillary fibroelastoma: Increasing recognition of a surgical disease. Ann Thorac Surg. 1999, 68: 1881-5. 10.1016/S0003-4975(99)00860-7.View ArticlePubMedGoogle Scholar
- Mohammadi S, Martineau A, Voisine P, Dagenais F: Left atrial papillary fibroelastoma: A rare cause of multipl cerebral emboli. Ann Thorac Surg. 2007, 84: 1396-7. 10.1016/j.athoracsur.2007.05.057.View ArticlePubMedGoogle Scholar
- Almagro UA, Perry LS, Choi H, Pintar K: Papillary fibroelastoma of the heart: Report of six cases. Arch Pathol Lab Med. 1982, 106: 318-21.PubMedGoogle Scholar
- Grandmougin D, Fayad G, Moukassa D, Decoene C, Abolmaali K, Bodart JC, Limousin M, Warembourg H: Cardiac valve papillary fibroelastomas: Clinical, histological and immunohistochemical studies and a physiopathogenic hypothesis. J Heart Valve Dis. 2000, 9: 832-41.PubMedGoogle Scholar
- Gabbieri D, Rossi G, Bavutti L, Corghi F, Zacà F, Sarandria D, Pierangeli A, Ghidoni I: Papillary fibroelastoma of the right atrium as an unusual source of recurrent pulmonary embolism. J Cardiovasc Med (Hagerstown). 2006, 7: 373-8.View ArticleGoogle Scholar
- Waltenberger J, Thelin S: Papillary fibroelastoma as an unusual source of repeated pulmonary embolism. Circulation. 1994, 89: 2433-View ArticlePubMedGoogle Scholar
- Kelle S, Chiribiri A, Meyer R, Fleck E, Nagel E: Papillary fibroelastoma of the tricuspid valve seen on magnetic resonance imaging. Circulation. 2008, 117: 190-1. 10.1161/CIRCULATIONAHA.107.729731.View ArticleGoogle Scholar
- Kondruweit M, Schmid M, Strecker T: Papillary fibroelastoma of mitral valve: appearence in 64-slice spiral computed tomography, magnetic resonance imaging, and echocardiography. Eur Heart J. 2008, 29: 831-10.1093/eurheartj/ehm475.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.